Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,824 | 26 | 55.1% |
| Consulting Fee | $18,728 | 6 | 28.8% |
| Travel and Lodging | $4,616 | 18 | 7.1% |
| Food and Beverage | $3,675 | 58 | 5.7% |
| Honoraria | $1,800 | 1 | 2.8% |
| Education | $321.04 | 8 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TherapeuticsMD, Inc. | $45,035 | 55 | $0 (2020) |
| Astellas Pharma US Inc | $13,107 | 31 | $0 (2024) |
| ABBVIE INC. | $3,675 | 1 | $0 (2022) |
| SCYNEXIS, Inc. | $1,114 | 2 | $0 (2022) |
| Amgen Inc. | $1,055 | 17 | $0 (2024) |
| Radius Health, Inc. | $254.78 | 3 | $0 (2019) |
| MAYNE PHARMA COMMERCIAL LLC | $124.87 | 1 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $119.90 | 1 | $0 (2017) |
| Johnson & Johnson Health Care Systems Inc. | $100.48 | 1 | $0 (2018) |
| PFIZER INC. | $95.20 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $496.46 | 13 | Astellas Pharma US Inc ($356.50) |
| 2023 | $747.98 | 16 | Amgen Inc. ($380.13) |
| 2022 | $7,826 | 5 | ABBVIE INC. ($3,675) |
| 2021 | $1,800 | 1 | Astellas Pharma US Inc ($1,800) |
| 2020 | $12,233 | 9 | TherapeuticsMD, Inc. ($10,433) |
| 2019 | $41,050 | 64 | TherapeuticsMD, Inc. ($34,602) |
| 2018 | $483.97 | 5 | Amgen Inc. ($308.80) |
| 2017 | $325.35 | 4 | Valeant Pharmaceuticals North America LLC ($119.90) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Biological | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Biological | ||||||
| 08/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Biological | ||||||
| 08/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: Biological | ||||||
| 08/07/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $115.32 | General |
| Category: Bone Health | ||||||
| 06/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Biological | ||||||
| 04/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Biological | ||||||
| 03/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: Biological | ||||||
| 03/11/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $90.00 | General |
| 03/05/2024 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Bone Health | ||||||
| 02/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Biological | ||||||
| 01/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Biological | ||||||
| 01/04/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.00 | General |
| 12/15/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Oral Contraceptive | ||||||
| 12/09/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $84.99 | General |
| 12/06/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $74.80 | General |
| Category: Bone Health | ||||||
| 11/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Biological | ||||||
| 11/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Education | In-kind items and services | $4.29 | General |
| Category: Biological | ||||||
| 11/01/2023 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Bone Health | ||||||
| 10/10/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Biological | ||||||
| 09/19/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Bone Health | ||||||
| 09/13/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $81.00 | General |
| Category: Rare Disease | ||||||
| 07/12/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $80.15 | General |
| Category: Bone Health | ||||||
| 05/09/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Bone Health | ||||||
| 04/20/2023 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $124.87 | General |
| Category: CONTRACEPTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 512 | 533 | $138,820 | $20,255 |
| 2022 | 4 | 229 | 243 | $82,088 | $14,654 |
| 2021 | 5 | 523 | 545 | $130,397 | $22,783 |
| 2020 | 6 | 497 | 505 | $123,559 | $17,952 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 211 | 232 | $96,608 | $14,706 | 15.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 255 | 255 | $18,615 | $2,320 | 12.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 17 | 17 | $11,385 | $1,559 | 13.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 16 | $9,456 | $1,525 | 16.1% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Facility | 2023 | 13 | 13 | $2,756 | $144.95 | 5.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 163 | 176 | $66,418 | $11,694 | 17.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 16 | 16 | $8,740 | $1,683 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 19 | 20 | $4,884 | $987.99 | 20.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2022 | 31 | 31 | $2,046 | $288.42 | 14.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 237 | 258 | $95,449 | $16,927 | 17.7% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Facility | 2021 | 243 | 244 | $16,104 | $2,334 | 14.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 14 | 14 | $7,264 | $1,507 | 20.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 15 | 15 | $8,220 | $1,296 | 15.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 14 | 14 | $3,360 | $718.68 | 21.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 225 | 233 | $83,387 | $12,145 | 14.6% |
| 77080 | Bone density measurement using dedicated x-ray machine | Facility | 2020 | 204 | 204 | $13,464 | $2,008 | 14.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 22 | 22 | $11,087 | $1,645 | 14.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 11 | 11 | $6,028 | $929.43 | 15.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 23 | 23 | $5,505 | $622.10 | 11.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 12 | 12 | $4,088 | $602.78 | 14.7% |
About Dr. Holly Thacker, MD
Dr. Holly Thacker, MD is a Internal Medicine healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427013598.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Holly Thacker, MD has received a total of $64,963 in payments from pharmaceutical and medical device companies, with $496.46 received in 2024. These payments were reported across 117 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,824).
As a Medicare-enrolled provider, Thacker has provided services to 1,761 Medicare beneficiaries, totaling 1,826 services with total Medicare billing of $75,645. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Cleveland, OH
- Active Since 04/20/2006
- Last Updated 02/22/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427013598
Products in Payments
- BIJUVA (Drug) $23,556
- ANNOVERA (Drug) $16,599
- IMVEXXY (Drug) $4,671
- ORIAHNN (Drug) $3,675
- EVENITY (Biological) $546.88
- Prolia (Biological) $412.66
- Veozah (Drug) $226.99
- Tymlos (Biological) $189.04
- NEXTSTELLIS (Drug) $124.87
- ADDYI (Drug) $119.90
- SIMPONI ARIA (Biological) $100.48
- PREMARIN ORALS (Drug) $95.20
- GARDASIL (Biological) $92.85
- ENDOMETRIAL ABLATION SYSTEM (Device) $86.37
- STRENSIQ (Biological) $81.00
- SLYND (Drug) $22.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cleveland
C Martin Harris, Md, MD
Internal Medicine — Payments: $1.1M
Marina Magrey, Md, MD
Internal Medicine — Payments: $491,321
Dr. Moshe Ornstein, Md Ma, MD MA
Internal Medicine — Payments: $250,140
Dr. Katherine Talcott, M.d, M.D
Internal Medicine — Payments: $248,994
Dr. Elliott Dasenbrook, Md, MD
Internal Medicine — Payments: $184,924
Syed Bukhari
Internal Medicine — Payments: $164,516